New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 20, 2014
09:10 EDTTLYS, BURL, GSK, DDD, CIDM, LEN, FSLR, XONE, BGMD, SNTA, SSYS, GESOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Burlington Stores (BURL), up 5%... Lennar (LEN), up 2%... BG Medicine (BGMD), up 16%. ALSO HIGHER: Synta Pharmaceuticals (SNTA), up 20% after announcing positive interim results from ganetespib trial... First Solar (FSLR), up 3.5% after the company's price target was raised at Deutsche Bank, JPMorgan and RW Baird following the company issued it FY15 outlook yesterday. DOWN AFTER EARNINGS: Guess (GES), down 5%... Tilly's (TLYS), down 7%... ExOne (XONE), down 12%. Peers in 3D space down as well, with 3D Systems down 3% and Stratasys (SSYS) down 2%. ALSO LOWER: Agenus (AGEN), down 18% after announcing that GlaxoSmithKline’s (GSK) MAGRIT study, which contains Agenus’QS-21 Stimulon adjuvant, did not meet its first or second co-primary endpoint... Cinedigm Digital (CIDM), down 12% after filing to sell common stock.
News For GES;XONE;DDD;SSYS;FSLR;GSK;SNTA;LEN;BURL;BGMD;CIDM;TLYS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
May 19, 2015
09:51 EDTDDDRumor: 3D Systems moves up on renewed takeover speculation
Subscribe for More Information
09:25 EDTGSKGlaxoSmithKline asthma drug overused, risks underappreciated, ProPublica says
Subscribe for More Information
09:08 EDTDDD3D Systems enters reseller agreement with Thermo Fisher
Subscribe for More Information
07:34 EDTLENJPMorgan to hold a conference
Subscribe for More Information
06:55 EDTGSKGenocea could be takeover target after data, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff expects Genocea Biosciences (GNCA) will report positive Phase II GEN-003 post-immunization results late in Q2. GEN-003 is a therapeutic vaccine for genital herpes targeting Herpes Simplex Virus Type 2. Positive GEN-003 data could position Genocea as a potential acquisition target by a larger vaccine player, Tenthoff tells investors today in a research note. Large vaccine makers include Sanofi (SNY), Merck (MRK), GlaxoSmithKline (GSK), Pfizer (PFE) and Novartis (NVS). The analyst reiterates an Overweight rating on Genocea with a $14 price target. Shares of the clinical-stage vaccine developer with a $227M market capitalization closed yesterday up 83c to $10.22.
May 18, 2015
09:07 EDTDDD3D Systems signs cooperative R&D agreement with NAVSEA
3D Systems announced a new cooperative R&D agreement with Naval Sea Systems Command's, or NAVSEA, Naval Surface Warfare Center Carderock Division, or NSWCCD. In accordance with this agreement, 3DS and the US Navy will jointly develop and evaluate 3D printing technology and materials for military uses, including helping the Navy fulfill a number of strategic initiatives. The US Navy's partnership with 3DS underscores the disruptive potential of 3D printing to redefine the supply chain for naval ship components, and reinforces 3DS' ability to continue to modernize the U.S. defense industrial base.
08:05 EDTCIDMCinedigm to add two to four new directors, including new Chairman, to board
Subscribe for More Information
07:10 EDTDDD3D Systems CFO transition negative, says RBC Capital
Subscribe for More Information
05:42 EDTDDD3D Systems to host analyst meeting
Subscribe for More Information
May 15, 2015
17:08 EDTLENSoros Fund gives quarterly update on stakes
Subscribe for More Information
15:11 EDTGSKGlaxoSmithKline reports 16.12% stake in HTG Molecular
Subscribe for More Information
10:01 EDTLENOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:31 EDTDDD, GSKAmerican Thoracic Society to hold a conference
ATS 2015 Conference is being held in Denver on May 15-20.
09:11 EDTDDDOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Bsquare (BSQR), up 34.2%... Applied Materials (AMAT), up 3.2%. ALSO HIGHER: Trillium Therapeutics (TRIL), up 13% after being initiated with an Outperform at Oppenheimer... Pernix Therapeutics (PTX), up 7.4% after announcing FDA approval of Treximet for use in pediatric patients... Advaxis (ADXS), up 4.4% after being initiated with a Buy at Jefferies... Netflix (NFLX), up 3.3% following a Bloomberg report that the company is in talks to enter China's online video market... Inovalon (INOV), up 2.9% after being upgraded to Buy from Neutral at Goldman. DOWN AFTER EARNINGS: El Pollo LoCo (LOCO), down 12.8%... King Digital (KING), down 8.3%. ALSO LOWER: PlasmaTech (PTBI), down 5.4% after filing to sell 1.93M shares for selling stockholders... Paycom Software (PAYC), down 7% after 8M share Spot Secondary priced at $36.25... Keurig Green Mountain (GMCR), down 5.9% after Keurig Kold investor presentation... 3D Systems (DDD), down 2.4% after CFO transition... Celladon (CLDN), down 5.1% after the CEO says that the company is evaluating strategic options.
08:33 EDTLENLennar downgraded to Market Perform from Outperform at Raymond James
Subscribe for More Information
08:33 EDTDDD3D Systems announces mutual separation agreement with CFO Hull, Styka to succeed
3D Systems announced that it entered into a mutual separation agreement with Ted Hull, its Chief CFO, effective as of the end of the day on May 15, pursuant to which Hull will leave the company in order to meet company needs and to pursue his personal interests. The company further announced that David Styka, the company's current Chief Accounting Officer, has been named executive vice president and CFO effective as of Hull's departure.
06:56 EDTXONEExOne receives standard Nasdaq notice relating to delay in filing Q1 10-Q
ExOne announced that it received notice from The Nasdaq Listing Qualifications Department on May 12, 2015, stating that ExOne is not in compliance with Nasdaq Listing Rule 5250c1, which requires the timely filing of all periodic reports with the SEC. The company received the notice because it has not yet filed its Form 10-Q for the quarter ended March 31, 2015 with the SEC. As previously announced on May 11, 2015, ExOne filed a Form 12b-25 Notification of Late Filing with the SEC reporting a delay in filing its 10-Q. The delay is due to unforeseen difficulties with respect to the implementation of the first phase of its new Enterprise Resource Planning software system in ExOne GmbH, its largest operating subsidiary. The Company expects to file its 10-Q with the SEC in early June 2015. This press release is being issued in accordance with Nasdaq Listing Rule 5810b.
May 14, 2015
07:49 EDTBGMDBG Medicine reports Q1 EPS (4c), one estimate (3c)
Subscribe for More Information
May 13, 2015
11:38 EDTGSKGlaxoSmithKline downgraded to Neutral from Buy at UBS
Subscribe for More Information
07:07 EDTGSKGSK, Emergent BioSolutions, Oxford initiate Prime Boost study of Ebola vaccine
A new phase 1 study has begun at the University of Oxford that will investigate the use of a modified vaccinia Ankara, or MVA, Ebola Zaire vaccine candidate, or MVA EBOZ, as a prime-boost to GlaxoSmithKline's (GSK) Chimp Adenovirus type 3, or ChAd3, Ebola vaccine candidate. The study, being conducted by the clinical research group of Professor Adrian Hill of the Jenner Institute, has received regulatory approval to begin from the United Kingdom's Medicines and Healthcare Products Regulatory Agency, or MHRA. The phase 1 study has a planned enrollment of 38 volunteers of which 6 will receive MVA EBOZ only while the other 32 will receive ChAd3-EBO-Z prime followed by MVA EBOZ boost. Emergent BioSolutions (EBS) manufactured the supply of MVA EBOZ to be used in this phase 1 study, which is being conducted in the U.K. with support from the Wellcome Trust and the U.K. Department for International Development.
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use